|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7,230.00 JPY | -2.15% |
|
-4.12% | -12.29% |
| 06-15 | Goldman Sachs Upgrades Chugai Pharmaceutical to Buy from Neutral; Price Target is 8,950 Yen | MT |
| 05-26 | Major Asian Stock Markets Fall Amid Renewed Middle East Tensions | MT |
| Market Cap | 11,899B 73.67B 64.44B 59.43B 54.89B 104B 7,026B 106B 710B 279B 3,461B 277B 271B | P/E 2026 * |
23.9x | P/E 2027 * | 20.5x |
|---|---|---|---|---|---|
| Enterprise Value | 10,978B 67.96B 59.45B 54.83B 50.64B 96.1B 6,482B 97.71B 655B 257B 3,193B 255B 250B | EV / Sales 2026 * |
7.92x | EV / Sales 2027 * | 6.99x |
| Free-Float |
38.12% | Yield 2026 * |
1.85% | Yield 2027 * | 2.12% |
Last Transcript: Chugai Pharmaceutical Co., Ltd.
| 1 day | -2.15% | ||
| 1 week | -4.12% | ||
| Current month | -4.04% | ||
| 1 month | -2.67% | ||
| 3 months | -15.78% | ||
| 6 months | -14.31% | ||
| Current year | -12.29% |
| 1 week | 7,136 |  | 7,762 |
| 1 month | 7,136 | | 7,939 |
| Current year | 7,136 | | 10,700 |
| 1 year | 5,942 | | 10,700 |
| 3 years | 3,843 | | 10,700 |
| 5 years | 3,191 | | 10,700 |
| 10 years | 1,003.33 | | 10,700 |
| Manager | Title | Age | Since |
|---|---|---|---|
Osamu Okuda
CEO | Chief Executive Officer | 63 | 01/03/2021 |
Iwaaki Taniguchi
DFI | Director of Finance/CFO | 59 | 28/03/2024 |
Kazuhiko Nishi
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Osamu Okuda
BRD | Director/Board Member | 63 | 01/03/2020 |
Iwaaki Taniguchi
BRD | Director/Board Member | 59 | 28/03/2024 |
| Director/Board Member | 51 | 01/03/2025 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.15% | -4.12% | +5.03% | +87.84% | 75.29B | |
| -0.43% | -0.91% | +48.77% | +173.56% | 1,060B | |
| -0.11% | -0.81% | +64.04% | +61.98% | 619B | |
| -1.15% | -3.21% | +28.75% | +84.59% | 438B | |
| -0.94% | +0.72% | +29.69% | +24.89% | 333B | |
| -0.04% | -0.40% | +29.21% | +47.28% | 282B | |
| -1.71% | -10.31% | +18.61% | +22.42% | 267B | |
| -0.05% | +0.55% | -27.16% | -38.26% | 218B | |
| -1.65% | -1.96% | +20.95% | +57.81% | 196B | |
| -0.16% | -0.33% | +15.25% | +68.40% | 161B | |
| Average | -0.81% | -3.33% | +23.31% | +59.05% | 364.92B | |
| Weighted average by Cap. | -0.62% | -3.10% | +35.08% | +84.29% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1,387B 8.59B 7.51B 6.93B 6.4B 12.14B 819B 12.34B 82.77B 32.5B 403B 32.24B 31.54B | 1,537B 9.51B 8.32B 7.67B 7.09B 13.45B 907B 13.68B 91.7B 36.01B 447B 35.72B 34.94B |
| Net income | 509B 3.15B 2.75B 2.54B 2.35B 4.45B 300B 4.53B 30.36B 11.92B 148B 11.82B 11.57B | 594B 3.68B 3.22B 2.97B 2.74B 5.2B 351B 5.29B 35.47B 13.93B 173B 13.81B 13.51B |
| Net Debt | -921B -5.7B -4.99B -4.6B -4.25B -8.06B -544B -8.2B -54.98B -21.59B -268B -21.41B -20.95B | -1,166B -7.22B -6.31B -5.82B -5.38B -10.21B -688B -10.38B -69.59B -27.33B -339B -27.1B -26.51B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/07/26 | ¥7,230.00 | -2.15% | 2,054,100 |
| 10/07/26 | ¥7,389.00 | +0.41% | 2,663,200 |
| 09/07/26 | ¥7,359.00 | +0.19% | 2,213,200 |
| 08/07/26 | ¥7,345.00 | -3.61% | 3,515,600 |
| 07/07/26 | ¥7,620.00 | +1.05% | 2,451,200 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4519 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
